News

A major gift to Southern Illinois University School of Medicine will transform the health care of people throughout Illinois and beyond. Dale and Deborah Smith recently donated a substantial financial

Riluzole is an FDA-approved drug, currently used to treat amyotrophic lateral sclerosis (ALS; Lou Gehrig's disease) and is currently in a Phase II clinical trial for the treatment of mild Alzheimer’s

According to the National Institute on Aging, there are more than 41 million licensed drivers age 65 and older on the roads, up from 26 million just 20 years ago. As a person ages, changes in health

Medical researchers at SIU School of Medicine’s Neuroscience Institute are studying how the novel coronavirus may accelerate the progression of Alzheimer’s disease. Their data could help identify

The King’s Daughters Organization awarded the Center for Alzheimer’s Disease and Related Disorders (CADRD) a grant for $7,724 to support our Minds in Motion and Opening Minds Through Art (OMA) Beyond

In August 2020, Erin Hascup PhD, Alzheimer's Center Director, and Kevin Hascup PhD, Assistant Professor published "Toward refining Alzheimer's disease into overlapping subgroups." The topic of the

Erin Hascup, PhD , has been named as the new director of the SIU Center for Alzheimer’s Disease and Related Disorders (CADRD) beginning January 1, 2020. Tom Ala, MD, was serving as the interim

Written by Lauren Murphy | Photos by Jason Johnson Published in Aspect s magazine, Autumn 2017 (40-4) As American lifespans increase due to progress on other medical frontiers, the toll from Alzheimer

As American lifespans increase due to progress made on other medical frontiers, the toll from Alzheimer’s disease (AD) grows. More than 5 million Americans are living with the disease, and by 2050